Showing 1 - 2 results of 2 for search 'Michael Tveden Gundesen', query time: 0.04s Refine Results
  1. 1
    In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease

    In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease by Thomas Lund, Michael Tveden Gundesen, Annette Juul Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Jon Thor Asmussen, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias Schmidt Slørdahl, Hareth Nahi, Anders Waage, Niels Abildgaard, Fredrik Schjesvold, Nordic Myeloma Study Group

    Published 2024-04-01
    Get full text
    Article
  2. 2
    Novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma

    Novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma by Aric Anloague, Hayley M. Sabol, Japneet Kaur, Sharmin Khan, Cody Ashby, Carolina Schinke, C. Lowry Barnes, Farah Alturkmani, Elena Ambrogini, Michael Tveden Gundesen, Thomas Lund, Anne Kristine Amstrup, Thomas Levin Andersen, Marta Diaz-delCastillo, G. David Roodman, Teresita Bellido, Jesus Delgado-Calle

    Published 2024-11-01
    Get full text
    Article

Search Tools: